Palantir's Post-Earnings Crossroads: Wall Street's Bull-Bear Chasm Widens Even as the Numbers Dazzle

Palantir's record Q2 growth and guidance hike fail to erase valuation doubts, leaving shares 17% below November highs amid analyst split.

The most striking thing about Palantir's latest quarterly report isn't the growth itself — it's the way a single earnings release can push the stock up by more than a third in seven trading days and still leave the shares trading roughly 17 percent below their November peak. That tension, between extraordinary operational delivery and persistent valuation anxiety, has turned the stock into one of the most hotly contested names on Wall Street.

A Quarter That Forced the Language to Evolve

Palantir's own executives reached for the word "otherworldly" to describe the second quarter, and the figures justify the hyperbole. Revenue surged 93 percent to $1.935 billion, with the US commercial business nearly doubling — up 149 percent to $764 million — while US government revenue climbed 90 percent to $809 million. GAAP net income hit $1.062 billion, translating to a 55 percent margin, and the company's Rule-of-40 score — a metric blending growth and profitability — touched 155 percent, a level rarely seen in enterprise software.

The quarter also showcased deal-making at scale: 220 contracts closed above $1 million, 73 of them above $10 million, with the US commercial segment alone booking $2.132 billion in total contract value. Management responded by lifting full-year guidance to a range of $8.150 billion to $8.158 billion in revenue — roughly 82 percent annual growth — while raising adjusted operating income guidance to $4.889 billion to $4.897 billion and adjusted free cash flow to between $4.5 billion and $4.7 billion. Analysts broadly described the move as the largest guidance increase in the company's history.

The market's initial response was predictable: the stock climbed 36.25 percent within a week. But here's the wrinkle — even after that sprint, shares remain 5.22 percent in the red for the year and sit 17.26 percent below the 52-week high of €179.98 reached in November. One blockbuster quarter, it seems, cannot immediately erase months of accumulated valuation skepticism.

The Analyst Divide: From $245 to Deep Doubt

The post-earnings reaction from the sell side captures the schizophrenia perfectly. On August 4, the Deutsche Bank lifted its rating from Hold to Buy with a $200 price target, while Citi's Tyler Radke raised his target the same day from $200 to $245, citing accelerated growth, strength in the US business, and improved contract metrics. DA Davidson also moved its target from $175 to $200, bumping 2027 revenue estimates up 7 percent.

At the opposite end of the spectrum sits Michael Burry, who publicly lamented not having placed a larger bet against the stock. And Goldman Sachs, in a note released Friday, told clients that only one of two AI heavyweights — SpaceX or Palantir — currently merits a buy rating, without committing publicly to which one it prefers.

Benchmark chose caution on the same day the Deutsche Bank upgraded, maintaining a Hold rating despite the record guidance hike. The spread between those positions — from deep bearish fair-value estimates to $245 — is remarkable for a company that just delivered what even its skeptics acknowledge was a blowout quarter.

ARK's Exit, and the Rotation Within AI

Adding another layer of complexity, Cathie Wood's ARK Invest has been trimming Palantir positions in the days following the earnings release. On Thursday alone, the fund sold 70,259 shares worth roughly $11.4 million, continuing a selling streak that began earlier in the week. Notably, ARK simultaneously purchased stakes in SpaceX and Nvidia totaling nearly $37.6 million.

That pattern looks less like an abandonment of the Palantir thesis and more like classic profit-taking and portfolio rebalancing within the same AI theme. But it also signals that even the most committed technology investors are choosing to bank gains after a move of this magnitude rather than adding to positions.

Beyond the Balance Sheet: Partnerships and Friction

The growth story extends beyond the financials. On August 3, Palantir announced a partnership with Mercury Systems to integrate its Foundry software into Mercury's manufacturing operations — digital twins and automated material planning for US defense programs. It's another step in Palantir's strategy of embedding itself deeply into critical infrastructure, both government and commercial.

Yet that depth creates its own complications. The United Nations World Food Programme is reportedly extending its software contract with Palantir despite internal auditor concerns about dependency and cost. Separately, a report from the Center for International Corporate Tax Accountability and Research alleges the company paid an effective global tax rate of just 1.4 percent in 2025 on $1.6 billion in pre-tax profit, with no US federal tax. Whether those criticisms are fair or not, they accompany any company that grows this powerful this quickly.

Institutional behavior mirrors the broader ambivalence. Allied Private Wealth built a new position of 4,826 shares worth about $563,000 during the second quarter, while Abner Herrman & Brock reduced its holdings by 13.2 percent. Even among professional investors, there's no consensus on how much of the "otherworldly" growth is already priced in — or how much political and regulatory attention lies ahead.

The Takeaway: Buying Growth, and the Uncertainty Priced Alongside It

What makes Palantir unusual right now is that both the bull and bear cases can be argued from the same set of facts. Operationally, the company delivered: a 62 percent adjusted operating margin, a US commercial business that has more than quintupled since 2024, and raised guidance across the board. A $245 price target isn't pulled from thin air.

But with annualized volatility around 100 percent, this remains one of the most nerve-wracking stocks in the market. After a week of gains exceeding 30 percent, and with analyst targets spanning from deeply negative fair-value estimates to $245, buying Palantir today means purchasing not just growth but also the uncertainty about how much of it is already reflected in the price. That gap between operational strength and valuation skepticism is likely to define the stock's trajectory in the weeks ahead.